Skip to main content
Fig. 1 | Clinical Epigenetics

Fig. 1

From: 5-Hydroxymethylation alterations in cell-free DNA reflect molecular distinctions of diffuse large B cell lymphoma at different primary sites

Fig. 1

Overall survival (OS) (A) and progression-free survival (PFS) (B) of patients with nodal diffuse large B cell lymphoma (N-DLBCL) and extranodal DLBCL (EN-DLBCL). OS (C) and PFS (D) of patients with DLBCL at different primary sites. OS (E) and PFS (F) of IP-DLBCL patients and non-IP-DLBCL patients. LN-DLBCL, lymph node-involved DLBCL; PG-DLBCL, primary gastric DLBCL; PI-DLBCL, primary intestinal DLBCL; PT-DLBCL, primary testicular DLBCL; PCNS-DLBCL, primary central nervous system DLBCL; and IP-DLBCL: primary immune-privileged site-associated DLBCL

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us